SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending after the FDA signaled decisive action against non-approved compounded GLP-1 drugs, specifically mentioning companies like Hims & Hers for mass-marketing alternatives, leading to a referral to the Department of Justice. This has split the community, with some fearing severe repercussions and others seeing a buying opportunity, accusing "Big Pharma" of FUD.

WorldFinancial

World Liberty Financial (WLFI) is facing intense scrutiny from a House investigation into its $500 million investment deal with a UAE royal family member, which, coupled with recent price volatility, is driving polarized community debate. While some view the Trump-linked crypto project as a 'scam,' others are accumulating, seeing an undervalued opportunity tied to real-world asset tokenization and the future of decentralized finance.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

WEEDCOIN is trending as its community rallies around the upcoming 4/20 cultural event, highlighting its "culture-first" approach on Solana and emphasizing long-term building, future partnerships, and the broader mission of destigmatizing cannabis. Holders, many valuing privacy, are actively discussing sustained growth and the vision for a "Weed3" ecosystem.

Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Miami, FL.

Pulse Biosciences Inc

Pulse Biosciences is trending due to recent positive clinical data from its nPulse cardiac catheter feasibility studies, demonstrating strong procedural success, coupled with critical FDA designations and clearances for its proprietary nsPFA technology. The community is highly optimistic about this "game-changing" medical technology and the significant insider ownership, anticipating further growth.

ETF Opportunities Trust - T-Rex 2X Inverse MSTR Daily Target ETF

T-Rex 2X Inverse MSTR Daily Target ETF

MSTZ, a 2x inverse ETF targeting MSTR, is experiencing a sharp, high-volume decline, signaling a strong upward move in MicroStrategy and its Bitcoin holdings that has severely impacted inverse positions. The community is lamenting significant losses and discussing the inherent risks of leveraged products amidst the ongoing debate about MicroStrategy's Bitcoin strategy.

Stellantis NV engages in the designing, engineering, manufacturing, distributing, and selling of vehicles and components. It offers its products under the Abarth, Alfa Romeo, Chrysler, Citroën, Dodge, DS Automobiles, Fiat, Jeep, Lancia, Maserati, Opel, Peugeot, Ram Trucks, Vauxhall, Free2move, and Leasys brands. The company was founded on April 1, 2014 and is headquartered in Hoofddorp, the Netherlands.

Stellantis N.V

Stellantis is trending after announcing a multi-billion dollar strategic charge to reset its electrification strategy, including pulling back on some EV plans and suspending its 2026 dividend. This move has triggered significant debate among investors about whether the resulting stock plunge is an overreaction or a justified response to an automotive sector grappling with evolving EV demand.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. It provides online news services where users can select and rank web content. The firm also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is a trending topic after its strong Q4 earnings report, featuring impressive revenue beats and a $1 billion share buyback, surprisingly led to a notable stock decline. This unusual price action is fueling community discussions, with many investors viewing the dip as a value opportunity given Reddit's crucial role in providing human-generated data for AI models.

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

A fervent "Mullen Army" is actively pushing for price appreciation of the MULN crypto token on the Solana network, citing perceived utility and potential for significant runs. However, a larger chorus of skeptics and former investors vehemently labels it a "scam," drawing strong parallels to the original Mullen Automotive stock's history of dilution, reverse splits, and reported investor losses.

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Regenxbio Inc

Regenxbio is trending due to an FDA clinical hold on its RGX-111 and RGX-121 gene therapies following a potential brain tumor in a trial patient, prompting significant community concern about an imminent Complete Response Letter for RGX-121's regulatory decision. Investors are debating whether the adverse event indicates a broader platform risk for its AAV9 vector and the stock's potential downside, while some hope for a delay rather than an outright rejection.

Tidal Trust II - Defiance Daily Target 2X Long ORCL ETF

Defiance Daily Target 2X Long ORCL ETF

ORCX is trending with intense community discussion amid high volatility, as traders are sharply divided between those frustrated by recent declines and others aggressively buying the dip, betting on a strong rebound for the underlying Oracle ($ORCL) stock, driven by its AI initiatives and TikTok partnership.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$LCDL
Current Stock Price: $2.95
Contracts to trade: $3.0 LCDL Feb 20 2026 Call
Entry: $0.72
Exit: $1.05
ROI: 46%
Hold ~22 days

Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

AI Powered Insights Get daily AI-generated picks that are primed to give you an edge. Join thousands of users who are getting smarter with our insights. Join thousands of users getting insightful AI-powered content delivered daily. 100% Free * No Credit Card Required * Disclaimer: The information provided is for educational purposes only and should not be considered professional advice.

Dailypickai

DailyPickAI

StockTwits Web

GraniteShares 2x Long LCID Daily ETF


Current Stock Price: $2.95
Contracts to trade: $3.0 LCDL Feb 20 2026 Call
Entry: $0.72
Exit: $1.05
ROI: 46%
Hold ~22 days

Shared as daily free alerts and for educational purposes only. 